Entry |
|
Name |
Tolazoline;
4,5-Dihydro-2-(phenylmethyl)-1H-imidazole
|
Formula |
C10H12N2
|
Exact mass |
160.1
|
Mol weight |
160.2157
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
C04AB Imidazoline derivatives
C04AB02 Tolazoline
D08614 Tolazoline (INN)
M MUSCULO-SKELETAL SYSTEM
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AX Other topical products for joint and muscular pain
M02AX02 Tolazoline
D08614 Tolazoline (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01466 Adrenergic receptor antagonist
DG01465 alpha-Adrenergic receptor antagonist
DG00281 Tolazoline
D08614 Tolazoline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D08614 Tolazoline (INN)
ADRA2
D08614 Tolazoline (INN)
|
Other DBs |
|
KCF data |
ATOM 12
1 C8x C 21.1400 -17.9900
2 C8x C 21.1400 -19.3900
3 C8x C 19.9500 -20.0900
4 C8x C 18.6900 -19.3900
5 C8x C 18.6900 -17.9900
6 C8y C 19.9500 -17.2900
7 C1b C 19.9500 -15.8900
8 C2y C 21.1400 -15.1900
9 N2x N 21.1400 -13.7900
10 C1x C 22.4700 -13.3700
11 C1x C 23.3100 -14.4900
12 N1x N 22.4700 -15.6100
BOND 13
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 6 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 1
12 11 12 1
13 8 12 1
|